Viewing StudyNCT00120861



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00120861
Status: COMPLETED
Last Update Posted: 2010-06-10
First Post: 2005-07-11

Brief Title: Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Organization Data

Organization: Merck Sharp Dohme LLC
Class: INDUSTRY
Study ID: NV-08A-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Merck Sharp Dohme LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators